David T. Dexter

23.7k citations

136 papers · 16.4k indexed · 7 hit papers · h-index 58

Impact in

Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological diseases and metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
Cellular and Molecular Neuroscience top 0.1%
- Neuroscience and Neuropharmacology Research
- Nuclear Receptors and Signaling

Papers in

Neurology 78
- Parkinson's Disease Mechanisms and Treatments 67
- Neurological disorders and treatments 25
- Neurological diseases and metabolism 20
- Neuroinflammation and Neurodegeneration Mechanisms 11
Cellular and Molecular Neuroscience 40
- Neuroscience and Neuropharmacology Research 16
- Nuclear Receptors and Signaling 13

Co-authors: C. D. Marsden Peter Jenner Anthony H.V. Schapira Andrew J. Lees F. R. Wells Jonathan M. Cooper Yves Agid J. B. Clark
Journals: Journal of Neurochemistry (12 papers)Journal of Neural Transmission (9 papers)Annals of Neurology (7 papers)Movement Disorders (5 papers)Biochemical Pharmacology (5 papers)
Partner nations: United Kingdom Belgium United States

In The Last Decade

David T. Dexter

134 papers receiving 16.1k citations

Hit Papers

7 papers align trajectories log scale

Parkinson disease: from pathology to molecular disease mechanisms 2013 · 528 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Free Radical Biology and Medicine
1994 Annals of Neurology
1991 Brain
1990 Journal of Neurochemistry
1990 Journal of Neurochemistry
1989 Journal of Neurochemistry
1989 Journal of Neurochemistry

Peers

Countries citing papers authored by David T. Dexter

Since Specialization

Citations

This map shows the geographic impact of David T. Dexter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Dexter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Dexter more than expected).

Fields of papers citing papers by David T. Dexter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Dexter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Dexter. The network helps show where David T. Dexter may publish in the future.

Co-authors

The 25 scholars most cited alongside David T. Dexter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David T. Dexter Line = papers co-authored together David T. Dexter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advances npj Parkinson s Disease ·Tiago Mestre, Glenn T. Stebbins, Diane Stephenson, David T. Dexter, Karen K. Lee, Yuge Xiao, Tien Dam, Catherine Kopil, Tanya Simuni	2024	4
2	Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease Journal of Neural Transmission ·Antonio Martín‐Bastida, Bension S. Tilley, Sukhvinder S. Bansal, Steve Gentleman, David T. Dexter, Roberta J. Ward	2020	37
3	DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats Neurotherapeutics ·Puneet Sharma, Lisa Wells, Gaia Rizzo, Joanna L. Elson, Jan Passchier, Eugenii A. Rabiner, Roger N. Gunn, David T. Dexter, Ilse S. Pienaar	2020	21
4	Quantification of blood–brain barrier transport and neuronal toxicity of unlabelled multiwalled carbon nanotubes as a function of surface charge Nanoscale ·Daniel Gonzalez‐Carter, Angela E. Goode, Darya Kiryushko, Seigo Masuda, Sheng Hu, Rosália Lopes Rodrigues, David T. Dexter, Milo S. P. Shaffer, Alexandra E. Porter	2019	33
5	Iron as a therapeutic target for Parkinson's disease Movement Disorders ·Caroline Moreau, James A. Duce, Olivier Rascol, Jean‐Christophe Devedjian, Daniela Berg, David T. Dexter, Zvi-Ioav Cabantchik, Ashley I. Bush, David Devos, (unknown)	2018	101
6	ALTERED BRAIN IRON HOMEOSTASIS IN PARKINSON'S DISEASE AND THE POTENTIAL FOR IRON CHELATION THERAPY UCL Discovery (University College London) ·David T. Dexter, Richard A. Ward, Robert R. Crichton, Kallo, (unknown)	2013	2
7	Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study Acta Neuropathologica ·Pascal F. Durrenberger, Francisca S. Fernando, Roberta Magliozzi, Samira N. Kashefi, Timothy P. Bonnert, Isidró Ferrer, Danielle Seilhean, Brahim Nait‐Oumesmar, Andrea Schmitt, Peter J. Gebicke‐Haerter, Peter Falkai, Edna Grünblatt, Miklós Palkovits, Piero Parchi, Sabina Capellari, Thomas Arzberger, Hans A. Kretzschmar, Federico Roncaroli, David T. Dexter, Richard Reynolds	2012	97
8	Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study Parkinson s Disease ·Pascal F. Durrenberger, Edna Grünblatt, Francesca S. Fernando, Camelia Maria Monoranu, Jordan Evans, Peter Riederer, Richard Reynolds, David T. Dexter	2012	55
9	Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease Free Radical Biology and Medicine ·Lauren Broom, L Marinova-Mutafchieva, Mona Sadeghian, John B. Davis, Andrew D. Medhurst, David T. Dexter	2010	80
10	Additive neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson's model Neuroreport ·Anthony C. Vernon, Martin J. Croucher, David T. Dexter	2008	19
11	Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease Free Radical Research ·Virginia Zbarsky, Krishna P. Datla, Shabnam Parkar, K. Deepal, Okezie I. Aruoma, David T. Dexter	2005	363
12	Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females Neuroscience ·Hilary E. Murray, Arani V. Pillai, Simon McArthur, Nihal Razvi, Krishna P. Datla, David T. Dexter, Glenda E. Gillies	2003	163
13	Parkinson's disease: an update* Neuropathology and Applied Neurobiology ·Manuel B. Graeber, David T. Dexter, R. K. B. Pearce, Richard Reynolds	2003	3
14	Nigral dopaminergic cell loss in vitamin E deficient rats Neuroreport ·David T. Dexter, Ishanthi Nanayakkara, Mark Goss‐Sampson, D. P. R. Muller, Anita E. Harding, C. D. Marsden, Peter Jenner	1994	40
15	The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase Neuroscience Letters ·Angela Clow, Clare Freestone, Emma Lewis, David T. Dexter, Merton Sandler, Vivette Glover	1993	34
16	ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA Brain ·David T. Dexter, A. Carayon, F. Javoy‐Agid, Yves Agid, F. R. Wells, S. E. Daniel, Andrew J. Lees, Peter Jenner, C. D. Marsden Hit paper breakdown →	1991	858
17	(?)-Deprenyl can induce soluble superoxide dismutase in rat striata Journal of Neural Transmission ·Angela Clow, Tabasum Hussain, Vivette Glover, M. Sandler, David T. Dexter, Martin J. Walker	1991	32
18	Mitochondrial Complex I Deficiency in Parkinson's Disease Journal of Neurochemistry ·Anthony H.V. Schapira, Jonathan M. Cooper, David T. Dexter, J. B. Clark, Peter Jenner, C. D. Marsden Hit paper breakdown →	1990	1788
19	A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra Journal of Neurochemistry ·H K Saggu, Jon D. Cooksey, David T. Dexter, F. R. Wells, Andrew J. Lees, Peter Jenner, C. D. Marsden	1989	374
20	A Comparative Analysis of the Phenotypic Characteristics of Available Fusion Partners for the Construction of Human Hybridomas Hybridoma ·Danuta Kozbor, David T. Dexter, John Roder	1983	22

About David T. Dexter

David T. Dexter is a scholar working on Neurology, Neurology, Cellular and Molecular Neuroscience, Physiology and Biochemistry, having authored 136 papers that have together received 16.4k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (67 papers), Neurological disorders and treatments (25 papers), Neurological diseases and metabolism (20 papers), Alzheimer's disease research and treatments (16 papers), Neuroscience and Neuropharmacology Research (16 papers), Nuclear Receptors and Signaling (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Trace Elements in Health (9 papers). The work is most often cited by research in Neurology (7.6k citations), Neurology (3.2k citations), Cellular and Molecular Neuroscience (5.1k citations), Biological Psychiatry (479 citations) and Physiology (3.2k citations). David T. Dexter has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include C. D. Marsden, Peter Jenner, Anthony H.V. Schapira, Andrew J. Lees, Peter Jenner, F. R. Wells, Jonathan M. Cooper, Yves Agid, J. B. Clark and Roberta J. Ward. Their work appears in journals such as Journal of Neurochemistry, Journal of Neural Transmission, Annals of Neurology, Movement Disorders and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact